Professional Documents
Culture Documents
saluran kencing)
Obat pada ISK
Early detection/Rx →penting untuk mencegah infeksi sistemik
&bacteremia
Antibiotik hanya direkomendkan jika diagnosis telah ditegakkan
Selection of antibiotic must be individualized and consider:
Side effect profile
Cost
Bacterial resistance
Effect of impaired renal function on dosing
Possible adverse drug reactions ↑ in elderly (multiple drugs, co-morbidities.
Osborne, 2004
Swart et al. 2004
Treatment Plan
Recommended Treatment Regimens for Acute, Uncomplicated UTI’s in the Elderly
Bacterial
Common Compliance/ Cost Wom
Treatment Dosage/Duration Coverage/ Men
Side Effects Convenience I/E en
Resistance
Sulfonamide Fair/Good
160/800 mg po bid x 3-14* days (E. coli 20%)
Trimethoprim- √
*available in a syrup ↑ resistance nausea, rash I √
Sulfamethoxazole longer duration of
If CrCl <15-30 mL/min, ↓in half Less effective
TMP-SMX bid ↓ compliance
Fluoroquinolones
100- 250 mg po bid x 3-14* days Good/Good
Ciprofloxacin (2nd
If CrCL <30mL/min ↓ by half bid, longer
gen) headache,
gram (-) effective duration ↓ √ √
dizziness, E
250 mg po daily x 10 days gram (+) only fair compliance
Levofloxacin (3 rd
nausea, diarrhea
(complicated upper and lower Excellent
gen)
UTI)
VE, often
3 g powder, dissolved in water gram (-) effective diarrhea, vaginitis, √ √
Fosfomycin Excellent not on
*single dose gram (+) less effective nausea, rhinitis
formularies
nausea, vaginitis,
100 mg po bid x 7 days Narrow spectrum diarrhea Fair Prostat
Nitrofurantoin √
If CrCL <40 mL/min gram (-) effective ↑ rate of severe 7-day regimen & I itis
(Macrobid)
not recommended gram (+) effective pulmonary & bid, ↓ compliance NR
hepatotoxicity
↑ resistance 2° Beta
Miscellaneous
Lactamase enzymes in
Beta Lactam AB’s:
resistant bacteria PCN-anaphylaxis Prostat
Cephalosporins (Cefuroxime, cefpodoxime) √
2nd/3rd gen Abdominal Fair for bid dosing I itis
Penicillins (ampicillin), Carbapenems (imipenem)
Cephalosporins cramping diarrhea NR
Phenazopyridine (Pyridium)—not appropriate
>resistant to beta
for elderly or patients with renal insufficiency
lactamase
Data adapted from Swart et al. (2004), Osborne (2004), Wagenlehner et al. (2005), Mahan-Buttaro et al.
(2006) and Evercare Corp (2004)
I = inexpensive; E = expensive; VE = very expensive; NR = not recommended
*Longer duration for complicated UTI per individual’s clinical status
Treatment Plan
Duration of Antibiotic Therapy: Ongoing Debate
Research
usually recommended.
Wagenlehner et al. 2005
Treatment Plan
Complicated UTI
Associated with azotemia, obstruction, or indwelling foley
Can lead to bacteremia, life-threatening systemic infection